FDA-cleared AI diagnostics cut false negatives by 43% in 2026

A comparison of FDA-cleared AI diagnostic tools shows a 43% reduction in false negative rates while maintaining clinical specificity. These AI platforms scan X-rays to flag cavities, bone loss, and early disease in seconds. The ADA recommends a 90-day implementation timeline. Availability in India is limited but growing; cost varies by software license, typically ₹50,000–₹2,00,000 annually per clinic.